Modern Africa Today
SEE OTHER BRANDS

Your daily news update on Africa

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on May 15, 2025

U.S. based artist Ayana Soyini debuts new single ‘Showers of Blessing’ & launches Africa media tour starting in Nigeria

U.S. based artist Ayana Soyini debuts new single ‘Showers of Blessing’ & launches Africa media tour starting in Nigeria

NEW YORK, NY, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- The versatile artist, DJ and producer, Ayana Soyini, is set to once again captivate a global audience with the release of her powerful new single, ‘Showers of Blessing’. With a calming and …

CREDAI Andhra Pradesh Steps Forward For Amravati’s Growth -  Hydromo Supports

CREDAI Andhra Pradesh Steps Forward For Amravati’s Growth - Hydromo Supports

CREDAI AP 2025, Crowning The Torchbearers, May 13, Tuesday VIJAYAWADA, ANDRAPRADESH, INDIA, May 15, 2025 /⁨EINPresswire.com⁩/ -- The Confederation of Real Estate Developers' Associations of India (CREDAI Andhra Pradesh) welcomed its new leadership team …

MADS Launches to Transform Media, Advertising & Communication Sectors

MADS Launches to Transform Media, Advertising & Communication Sectors

Where Industry Grows its People JOHANNESBURG, GAUTENG, SOUTH AFRICA, May 15, 2025 /⁨EINPresswire.com⁩/ -- Media Advertising Development Services — officially launched to reshape the future of the Media, Advertising, and Communication sectors. Hosted at …

Medical Benevolence Foundation Announces CEO Transition: Andy Mayo Retires, Gregory Nikkel Named Interim CEO

Medical Benevolence Foundation Announces CEO Transition: Andy Mayo Retires, Gregory Nikkel Named Interim CEO

SUGAR LAND, TX, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- Medical Benevolence Foundation (MBF) announces the retirement of Chief Executive Officer E. Andrew Mayo, who has faithfully served the organization for 13 years. Effective May 1, Mayo …

What’s Next for Gold? Joe DiNapoli Shares 2025 Forecast with EBC Financial Group

What’s Next for Gold? Joe DiNapoli Shares 2025 Forecast with EBC Financial Group

Joe DiNapoli forecasts a bullish 2025 for gold using his technical method, assigning just a 10% chance of prices hitting $10,000 amid global risks. THAILAND, May 15, 2025 /⁨EINPresswire.com⁩/ -- Against a backdrop of economic uncertainty, trade tensions, …

Isilumko Staffing Celebrates 30 years of excellence in recruitment.

Isilumko Staffing Celebrates 30 years of excellence in recruitment.

Isilumko Staffing, a leader in the South African recruitment industry, is proud to announce its 30th anniversary JOHANNESBURG, GAUTENG, SOUTH AFRICA, May 15, 2025 /⁨EINPresswire.com⁩/ -- Isilumko Staffing, a prominent name in the South African recruitment …

NIPES Announces 2025 Global Award Winners Honoring Excellence in Science, Engineering, and Innovation

NIPES Announces 2025 Global Award Winners Honoring Excellence in Science, Engineering, and Innovation

MA, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- The National Institute of Professional Engineers and Scientists (NIPES) proudly announces the recipients of the 2025 NIPES Global Awards, a groundbreaking international honor recognizing exemplary …

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

Conference call begins at 10:00 a.m. Eastern time on Friday, May 16, 2025 WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic …

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update

Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for …

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025

New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients  Additional Research Includes Acromegaly Symptom Burden and Standard-of-Care Discontinuation Rates  SAN DIEGO, …

Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results

Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results

Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the …

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected to enter IND-enabling studies in mid …

Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update

Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update

LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States ISELIN, N.J., May 15, 2025 (GLOBE …

Paul Beaubrun Joins Forces With 'Rasin' Music  Pioneer Dadi Beaubrun for 'Gade Sa Yo Fè Mwen' Remix

Paul Beaubrun Joins Forces With 'Rasin' Music Pioneer Dadi Beaubrun for 'Gade Sa Yo Fè Mwen' Remix

NEW YORK, NY, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- “Growing up watching my uncle, Daniel ‘Dadi’ Beaubrun, perform on stage with my parents in Boukman Eksperyans was something special,” says Paul Beaubrun, the Haitian Rasin/Rock artist. “As …

Lancaster Granted Exploration License at Lake Cargelligo Gold Project

Lancaster Granted Exploration License at Lake Cargelligo Gold Project

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce that the vendor of the Lake Cargelligo Gold Project received final approval from the State of New …

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

Biofrontera has received patent approval for the revised formulation of Ameluz®, which extends patent protection through to December 2043 Ameluz PDT offers the potential for effective treatment of moderate to severe acne without the side effects associated …

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

In a release issued under the same headline earlier today by Mersana Therapeutics, Inc. (NASDAQ: MRSN), please note that there was a transcription error in the last cell of the first table. The Median OS should have been 5.7 months rather than 1.7 months.  …

Silo Pharma Announces Pricing of $2 Million Public Offering

Silo Pharma Announces Pricing of $2 Million Public Offering

SARASOTA, FL, May 15, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the pricing of a public …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service